text: <unk>  is a monoclonal antibody that is FDA approved for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). There is a Black Box Warning for this drug as shown here.  Common adverse reactions include cytopenias, infusion reactions, cytomegalovirus (CMV) and other infections, nausea, diarrhea and insomnia.
option_0: Alemtuzumab
option_1: Ruxolitinib
option_2: Bavituximab
option_3: Rituximab
option_4: Lenalidomide
option_5: Ibrutinib
option_6: Bosutinib
option_7: Acalabrutinib